These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 23665287)

  • 1. Comparative genetic analyses point to HCP5 as susceptibility locus for HCV-associated hepatocellular carcinoma.
    Lange CM; Bibert S; Dufour JF; Cellerai C; Cerny A; Heim MH; Kaiser L; Malinverni R; Müllhaupt B; Negro F; Semela D; Moradpour D; Kutalik Z; Bochud PY;
    J Hepatol; 2013 Sep; 59(3):504-9. PubMed ID: 23665287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms in MICA, but not in DEPDC5, HCP5 or PNPLA3, are associated with chronic hepatitis C-related hepatocellular carcinoma.
    Hai H; Tamori A; Thuy LTT; Yoshida K; Hagihara A; Kawamura E; Uchida-Kobayashi S; Morikawa H; Enomoto M; Murakami Y; Kawada N
    Sci Rep; 2017 Sep; 7(1):11912. PubMed ID: 28928439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma.
    Kumar V; Kato N; Urabe Y; Takahashi A; Muroyama R; Hosono N; Otsuka M; Tateishi R; Omata M; Nakagawa H; Koike K; Kamatani N; Kubo M; Nakamura Y; Matsuda K
    Nat Genet; 2011 May; 43(5):455-8. PubMed ID: 21499248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between MICA rs2596542 Polymorphism with the Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients.
    Marangon CG; de Bitencorte JT; Michita RT; Lunge VR; Dos Santos DC; Álvares-da-Silva MR; Simon D
    Pathol Oncol Res; 2020 Jul; 26(3):1519-1525. PubMed ID: 31471884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between the rs2596542 polymorphism in the MICA gene promoter and HBV/HCV infection-induced hepatocellular carcinoma: a meta-analysis.
    Luo X; Wang Y; Shen A; Deng H; Ye M
    BMC Med Genet; 2019 Aug; 20(1):142. PubMed ID: 31419949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replication of genome wide association studies on hepatocellular carcinoma susceptibility loci in a Chinese population.
    Chen K; Shi W; Xin Z; Wang H; Zhu X; Wu X; Li Z; Li H; Liu Y
    PLoS One; 2013; 8(10):e77315. PubMed ID: 24204805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a functional variant in the MICA promoter which regulates MICA expression and increases HCV-related hepatocellular carcinoma risk.
    Lo PH; Urabe Y; Kumar V; Tanikawa C; Koike K; Kato N; Miki D; Chayama K; Kubo M; Nakamura Y; Matsuda K
    PLoS One; 2013; 8(4):e61279. PubMed ID: 23593449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variation at -1878 (rs2596542) in MICA gene region is associated with chronic hepatitis B virus infection in Saudi Arabian patients.
    Al-Qahtani AA; Al-Anazi M; Abdo AA; Sanai FM; Al-Hamoudi W; Alswat KA; Al-Ashgar HI; Khalaf N; Viswan N; Al-Ahdal MN
    Exp Mol Pathol; 2013 Dec; 95(3):255-8. PubMed ID: 23994040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral Treatment.
    Huang CF; Huang CY; Yeh ML; Wang SC; Chen KY; Ko YM; Lin CC; Tsai YS; Tsai PC; Lin ZY; Chen SC; Dai CY; Huang JF; Chuang WL; Yu ML
    EBioMedicine; 2017 Feb; 15():81-89. PubMed ID: 27998720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between MICA Gene Variants and the Risk of Hepatitis C Virus-Induced Hepatocellular Cancer in a Sicilian Population Sample.
    Augello G; Balasus D; Fusilli C; Mazza T; Emma MR; Giannitrapani L; Agliastro R; Cervello M; Montalto G
    OMICS; 2018 Apr; 22(4):274-282. PubMed ID: 29584564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SNP rs2596542G>A in MICA is associated with risk of hepatocellular carcinoma: a meta-analysis.
    Wang H; Cao H; Xu Z; Wang D; Zeng Y
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30967497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.
    Matsuura K; Sawai H; Ikeo K; Ogawa S; Iio E; Isogawa M; Shimada N; Komori A; Toyoda H; Kumada T; Namisaki T; Yoshiji H; Sakamoto N; Nakagawa M; Asahina Y; Kurosaki M; Izumi N; Enomoto N; Kusakabe A; Kajiwara E; Itoh Y; Ide T; Tamori A; Matsubara M; Kawada N; Shirabe K; Tomita E; Honda M; Kaneko S; Nishina S; Suetsugu A; Hiasa Y; Watanabe H; Genda T; Sakaida I; Nishiguchi S; Takaguchi K; Tanaka E; Sugihara J; Shimada M; Kondo Y; Kawai Y; Kojima K; Nagasaki M; Tokunaga K; Tanaka Y;
    Gastroenterology; 2017 May; 152(6):1383-1394. PubMed ID: 28163062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of serial serum major histocompatibility complex class I chain-related A measurements with hepatocellular carcinoma in chronic hepatitis C patients after viral eradication.
    Huang CF; Wang SC; Yeh ML; Huang CI; Tsai PC; Lin ZY; Chen SC; Dai CY; Huang JF; Chuang WL; Chen A; Yu ML
    J Gastroenterol Hepatol; 2019 Jan; 34(1):249-255. PubMed ID: 29932235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble MICA and a MICA variation as possible prognostic biomarkers for HBV-induced hepatocellular carcinoma.
    Kumar V; Yi Lo PH; Sawai H; Kato N; Takahashi A; Deng Z; Urabe Y; Mbarek H; Tokunaga K; Tanaka Y; Sugiyama M; Mizokami M; Muroyama R; Tateishi R; Omata M; Koike K; Tanikawa C; Kamatani N; Kubo M; Nakamura Y; Matsuda K
    PLoS One; 2012; 7(9):e44743. PubMed ID: 23024757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepatitis C virus induced hepatocellular carcinoma associated genes].
    Kato N; Muroyama R; Goto K
    Nihon Rinsho; 2015 Feb; 73(2):333-8. PubMed ID: 25764692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MICA SNPs and the NKG2D system in virus-induced HCC.
    Goto K; Kato N
    J Gastroenterol; 2015 Mar; 50(3):261-72. PubMed ID: 25270965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DEPDC5 variants increase fibrosis progression in Europeans with chronic hepatitis C virus infection.
    Burza MA; Motta BM; Mancina RM; Pingitore P; Pirazzi C; Lepore SM; Spagnuolo R; Doldo P; Russo C; Lazzaro V; Fischer J; Berg T; Aghemo A; Cheroni C; De Francesco R; Fargion S; Colombo M; Datz C; Stickel F; Valenti L; Romeo S
    Hepatology; 2016 Feb; 63(2):418-27. PubMed ID: 26517016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TLR3 and TLR4 SNP variants in the liver disease resulting from hepatitis B virus and hepatitis C virus infection.
    Sghaier I; Zidi S; Mouelhi L; Ghazoueni E; Brochot E; Almawi WY; Loueslati BY
    Br J Biomed Sci; 2019 Jan; 76(1):35-41. PubMed ID: 30421643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC.
    Fabris C; Falleti E; Cussigh A; Bitetto D; Fontanini E; Bignulin S; Cmet S; Fornasiere E; Fumolo E; Fangazio S; Cerutti A; Minisini R; Pirisi M; Toniutto P
    J Hepatol; 2011 Apr; 54(4):716-22. PubMed ID: 21146242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphism of interleukin-16 influences susceptibility to HBV-related hepatocellular carcinoma in a Chinese population.
    Li S; Deng Y; Chen ZP; Huang S; Liao XC; Lin LW; Li H; Peng T; Qin X; Zhao JM
    Infect Genet Evol; 2011 Dec; 11(8):2083-8. PubMed ID: 22019522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.